New Delhi, May 31 (IANS) The US Food and Drug Administration (FDA) has flagged serious manufacturing, maintenance and data integrity lapses at a Dabur India manufacturing facility in Dadra and Nagar Haveli, at a time when Indian pharmaceutical and healthcare product makers are facing increased scrutiny from US regulators over quality standards and manufacturing practices.According to the FDA inspection report, the regulator identified multiple deficiencies at the plant, raising concerns over pot…
Trending
- Jeena Dil Se (2026) Review: A Colorful Musical Entertainer That Celebrates Life, Love & Friendship
- Phera Movie Review: Sanjay Mishra and Ritwick Chakraborty Deliver a Quietly Devastating Father-Son Drama
- Sandigdham Review: A Gripping Mystery Thriller That Slowly Gets Under Your Skin
- Mareechika (2026) Review: A Psychological Thriller That Weaves Mystery and Emotion Into a Compelling Cinematic Experience
- Krishna Aur Chitthi Review: Arun Govil and Darsheel Safary Deliver a Heartfelt Tale of Faith, Family, and Cricket
- Return Of The Jungle (2026) Movie Review: A Heartwarming Animated Journey Rooted in Indian Storytelling
- Shape of Momo Review: A Breathtaking Portrait of Womanhood, Patriarchy, and Belonging in the Hills of Sikkim
- Rajni Ki Baraat Review (2026): A Bold, Heartwarming Celebration of Female Courage from the Lanes of Darbhanga